Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.

Our observations suggest that a molecular-guided treatment approach is feasible for the management of advanced malignant mesothelioma. Our analysis revealed gender specific differences in PDGFRα expression that should be further evaluated in clinical trials.